September 1, 2014Indian Heart JournalOpen Access

Clopidogrel resistance: The way forward

View Full Paper

Ask AI

Bookmark

Population

Patients with Acute Coronary Syndrome (ACS) and clopidogrel resistance

Design

Review

Authors

SRShuvanan RayUniversidad de Oviedo

Discussion

Member takes

Implication

Clopidogrel resistance in ACS merits vigilance; leaves open standardized testing and new-agent strategies pending prospective trials.

Structured PICO

Population

Patients with Acute Coronary Syndrome (ACS) and clopidogrel resistance

Intervention

Clopidogrel and new generation antiplatelets

This review highlights the clinical impact of clopidogrel resistance in ACS patients, including increased mortality and stent thrombosis, and discusses alternative antiplatelet strategies.

Cite This Study

Shuvanan Ray (2014) studied this question.

synapsesocial.com/papers/6a6faeb3660549caf2c439e8 https://doi.org/10.1016/j.ihj.2014.08.012

Topics

Dual antiplatelet therapy

View Full Paper

Ask AI

Bookmark

Clopidogrel resistance: The way forward

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Clopidogrel resistance: The way forward

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider